Molecular Partners Ag (MOLN) FCF Margin Growth (1y) (2021 - 2026)
Molecular Partners Ag (MOLN) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 811.00 |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -292.00 |
| Dec 31, 2025 | -109.23 Mn |
| Sep 30, 2025 | 24.57 Mn |
| Jun 30, 2025 | 209.15 Bn |
| Mar 31, 2025 | 51,519.00 |
| Dec 31, 2024 | 120.74 Mn |
| Sep 30, 2024 | -116.48 Mn |
| Jun 30, 2024 | -209.17 Bn |
| Mar 31, 2024 | -61,822.00 |
| Dec 31, 2023 | -92,493.00 |
| Sep 30, 2023 | 116.48 Mn |
| Jun 30, 2023 | -842,455.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 7,711.00 |
| Sep 30, 2022 | -147.61 Mn |
| Jun 30, 2022 | 128,101.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 77.00 |